Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial

Abstract

Sitagliptin does not improve fibrosis score or NAS after 24 wk of therapy. The MRI IDEAL technique may be useful for non-invasive measurement of hepatic steatosis.